{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:55:47Z","timestamp":1740146147442,"version":"3.37.3"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["W81XWH-07-2-0067"],"award-info":[{"award-number":["W81XWH-07-2-0067"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0176428","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T18:14:45Z","timestamp":1494526485000},"page":"e0176428","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women"],"prefix":"10.1371","volume":"12","author":[{"given":"Peter B.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-5101","authenticated-orcid":true,"given":"Jean-Louis","family":"Excler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia D.","family":"Tomaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay N.","family":"Carpp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barton F.","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Xin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Montefiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supachai","family":"Rerks-Ngarm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punnee","family":"Pitisuttithum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sorachai","family":"Nitayaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaranit","family":"Kaewkungwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo H.","family":"Kijak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sodsai","family":"Tovanabutra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald P.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carter","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruk","family":"Sinangil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phillip W.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakorn","family":"Premsri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prayura","family":"Kunasol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"O\u2019Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merlin L.","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhoda","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Corey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"issue":"Suppl 1","key":"ref1","first-page":"24A","article-title":"Epidemiology of herpes simplex virus type 2 infection in the developing world","volume":"11","author":"H Weiss","year":"2004","journal-title":"Herpes"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1258\/ijsa.2011.011256","article-title":"Prevalence of Treponema pallidum seropositivity and herpes simplex virus type 2 infection in a cohort of men who have sex with men, Bangkok, Thailand, 2006\u20132010","volume":"23","author":"TH Holtz","year":"2012","journal-title":"Int J STD AIDS"},{"issue":"9605","key":"ref3","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","article-title":"Genital herpes","volume":"370","author":"R Gupta","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2471\/BLT.07.046128","article-title":"An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection","volume":"86","author":"KJ Looker","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics","volume":"35","author":"L Corey","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/tmi.12176","article-title":"Effect of HSV-2 on population-level trends in HIV incidence in Uganda between 1990 and 2007","volume":"18","author":"S Biraro","year":"2013","journal-title":"Trop Med Int Health"},{"issue":"10","key":"ref7","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1086\/374976","article-title":"How does herpes simplex virus type 2 influence human immunodeficiency virus infection and pathogenesis?","volume":"187","author":"A Wald","year":"2003","journal-title":"J Infect Dis"},{"issue":"6","key":"ref8","first-page":"447","article-title":"Genital herpes and human immunodeficiency virus: double trouble","volume":"82","author":"C Celum","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"EE Freeman","year":"2006","journal-title":"AIDS"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/QAI.0b013e31821acb5","article-title":"Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)","volume":"57","author":"RV Barnabas","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"12612","DOI":"10.1128\/JVI.01930-14","article-title":"Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans","volume":"88","author":"TM Cairns","year":"2014","journal-title":"J Virol"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/erv.12.129","article-title":"The challenge of developing a herpes simplex virus 2 vaccine","volume":"11","author":"LK Dropulic","year":"2012","journal-title":"Expert Rev Vaccines"},{"issue":"12","key":"ref13","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1172\/JCI57148","article-title":"HSV-2: in pursuit of a vaccine","volume":"121","author":"C Johnston","year":"2011","journal-title":"J Clin Invest"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.282.4.331","article-title":"Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group","volume":"282","author":"L Corey","year":"1999","journal-title":"JAMA"},{"issue":"21","key":"ref15","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"LR Stanberry","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa1103151","article-title":"Efficacy results of a trial of a herpes simplex vaccine","volume":"366","author":"RB Belshe","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/374002","article-title":"Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs","volume":"187","author":"N Bourne","year":"2003","journal-title":"J Infect Dis"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jri.2007.08.004","article-title":"Antibody-mediated protection against genital herpes simplex virus type 2 disease in mice by Fc gamma receptor-dependent and -independent mechanisms","volume":"78","author":"CF Chu","year":"2008","journal-title":"J Reprod Immunol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI114695","article-title":"Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B","volume":"86","author":"S Kohl","year":"1990","journal-title":"J Clin Invest"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/IAI.37.3.1132-1137.1982","article-title":"Protection against lethal challenge of BALB\/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2","volume":"37","author":"N Balachandran","year":"1982","journal-title":"Infect Immun"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/JVI.68.4.2118-2126.1994","article-title":"Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice","volume":"68","author":"H Ghiasi","year":"1994","journal-title":"J Virol"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88529","article-title":"HSV-2 DeltagD elicits FcgammaR-effector antibodies that protect against clinical isolates","volume":"1","author":"CD Petro","year":"2016","journal-title":"JCI Insight"},{"issue":"23","key":"ref23","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"S Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-med-052912-123749","article-title":"Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection","volume":"66","author":"JH Kim","year":"2015","journal-title":"Annu Rev Med"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/infdis\/jiq152","article-title":"Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials","volume":"203","author":"PB Gilbert","year":"2011","journal-title":"J Infect Dis"},{"issue":"14","key":"ref26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"BF Haynes","year":"2012","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"ref27","first-page":"S277","article-title":"Development of bivalent rgp120 vaccines to prevent HIV type 1 infection","volume":"14","author":"PW Berman","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4760","key":"ref28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1126\/science.3014647","article-title":"Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope glycoprotein","volume":"233","author":"LA Lasky","year":"1986","journal-title":"Science"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.167.2.275","article-title":"Overlapping T cell antigenic sites on a synthetic peptide fragment from herpes simplex virus glycoprotein D, the degenerate MHC restriction elicited, and functional evidence for antigen-Ia interaction","volume":"167","author":"E Heber-Katz","year":"1988","journal-title":"J Exp Med"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4049\/jimmunol.135.2.1385","article-title":"The T cell response to the glycoprotein D of the herpes simplex virus: the significance of antigen conformation","volume":"135","author":"E Heber-Katz","year":"1985","journal-title":"J Immunol"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1128\/JVI.49.1.102-108.1984","article-title":"Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody","volume":"49","author":"GH Cohen","year":"1984","journal-title":"J Virol"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1128\/JVI.52.2.431-435.1984","article-title":"Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D","volume":"52","author":"B Dietzschold","year":"1984","journal-title":"J Virol"},{"issue":"17","key":"ref33","doi-asserted-by":"crossref","first-page":"9463","DOI":"10.1128\/JVI.77.17.9463-9473.2003","article-title":"Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity","volume":"77","author":"L BenMohamed","year":"2003","journal-title":"J Virol"},{"issue":"Pt 5","key":"ref34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1099\/vir.0.008771-0","article-title":"Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB\/c mice after DNA immunization and infection","volume":"90","author":"WJ Muller","year":"2009","journal-title":"J Gen Virol"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-3083.1994.tb03512.x","article-title":"The influence of branched polypeptide carriers on the immunogenicity of predicted epitopes of HSV-1 glycoprotein D","volume":"40","author":"A Hilbert","year":"1994","journal-title":"Scand J Immunol"},{"issue":"1\u20132","key":"ref36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01319007","article-title":"T cell responses to synthetic peptides of herpes simplex virus type 1 glycoprotein D in naturally infected individuals","volume":"130","author":"RA Damhof","year":"1993","journal-title":"Arch Virol"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1073\/pnas.82.10.3425","article-title":"Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D","volume":"82","author":"EC DeFreitas","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/JVI.53.2.634-644.1985","article-title":"Localization of epitopes of herpes simplex virus type 1 glycoprotein D","volume":"53","author":"RJ Eisenberg","year":"1985","journal-title":"J Virol"},{"issue":"18","key":"ref39","doi-asserted-by":"crossref","first-page":"9213","DOI":"10.1128\/JVI.01213-15","article-title":"Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific","volume":"89","author":"TM Cairns","year":"2015","journal-title":"J Virol"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"GE Crooks","year":"2004","journal-title":"Genome Res"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nbt0684-527","article-title":"Protection of Mice from Lethal Herpes-Simplex Virus-Infection by Vaccination with a Secreted Form of Cloned Glycoprotein-D","volume":"2","author":"LA Lasky","year":"1984","journal-title":"Bio-Technology"},{"issue":"4693","key":"ref42","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1126\/science.2983428","article-title":"Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D","volume":"227","author":"PW Berman","year":"1985","journal-title":"Science"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/infdis\/155.5.914","article-title":"Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes","volume":"155","author":"LR Stanberry","year":"1987","journal-title":"J Infect Dis"},{"issue":"5","key":"ref44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/infdis\/157.5.897","article-title":"Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs","volume":"157","author":"PW Berman","year":"1988","journal-title":"J Infect Dis"},{"issue":"19","key":"ref45","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM199911043411904","article-title":"A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group","volume":"341","author":"AG Langenberg","year":"1999","journal-title":"N Engl J Med"},{"issue":"8","key":"ref46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1086\/340041","article-title":"Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988\u20131994","volume":"185","author":"F Xu","year":"2002","journal-title":"J Infect Dis"},{"key":"ref47","unstructured":"U.S. National Institutes of Health. HIV Vaccine Trial in Thai Adults [November 15, 2016]. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00223080?term=rv144&rank=7\" xlink:type=\"simple\">https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00223080?term=rv144&amp;rank=7<\/ext-link>."},{"issue":"24","key":"ref48","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1128\/JVI.01708-08","article-title":"Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia","volume":"82","author":"GD Tomaras","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mi.2012.107","article-title":"HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life","volume":"6","author":"NL Yates","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1128\/JCM.26.4.662-667.1988","article-title":"Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera","volume":"26","author":"RL Ashley","year":"1988","journal-title":"J Clin Microbiol"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/JVI.50.2.547-554.1984","article-title":"Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2","volume":"50","author":"HS Marsden","year":"1984","journal-title":"J Virol"},{"issue":"18","key":"ref52","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1002\/sim.2771","article-title":"Sample size determination for logistic regression revisited","volume":"26","author":"E Demidenko","year":"2007","journal-title":"Statistics in Medicine"},{"issue":"22","key":"ref53","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"GD Tomaras","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"ref54","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1473-3099(12)70088-9","article-title":"Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B\/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144","volume":"12","author":"ML Robb","year":"2012","journal-title":"Lancet Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0176428","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T14:30:02Z","timestamp":1692801002000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0176428"}},"subtitle":[],"editor":[{"given":"Alan","family":"Landay","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0176428","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,5,11]]}}}